Detalles de la búsqueda
1.
Upadacitinib Induction and Maintenance Therapy for Crohn's Disease.
N Engl J Med
; 388(21): 1966-1980, 2023 May 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-37224198
2.
Reviewing the impact of obesity on inflammatory bowel disease and considerations for optimizing management.
Curr Opin Gastroenterol
; 2024 Apr 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-38662340
3.
Ustekinumab versus adalimumab for induction and maintenance therapy in biologic-naive patients with moderately to severely active Crohn's disease: a multicentre, randomised, double-blind, parallel-group, phase 3b trial.
Lancet
; 399(10342): 2200-2211, 2022 06 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-35691323
4.
Risankizumab as maintenance therapy for moderately to severely active Crohn's disease: results from the multicentre, randomised, double-blind, placebo-controlled, withdrawal phase 3 FORTIFY maintenance trial.
Lancet
; 399(10340): 2031-2046, 2022 05 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-35644155
5.
Risankizumab as induction therapy for Crohn's disease: results from the phase 3 ADVANCE and MOTIVATE induction trials.
Lancet
; 399(10340): 2015-2030, 2022 05 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-35644154
6.
Upadacitinib as induction and maintenance therapy for moderately to severely active ulcerative colitis: results from three phase 3, multicentre, double-blind, randomised trials.
Lancet
; 399(10341): 2113-2128, 2022 06 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35644166
7.
Inflammatory Bowel Disease Is Associated With an Increased Risk of Incident Acute Arterial Events: Analysis of the United Kingdom Biobank.
Clin Gastroenterol Hepatol
; 21(3): 761-770.e13, 2023 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-36075499
8.
Effectiveness of Hepatitis B Vaccination for Patients With Inflammatory Bowel and Celiac Disease.
Clin Gastroenterol Hepatol
; 21(11): 2901-2907.e2, 2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37004970
9.
Risk of Major Adverse Cardiovascular Events in Immune-Mediated Inflammatory Disorders on Biologics and Small Molecules: Network Meta-Analysis.
Clin Gastroenterol Hepatol
; 2023 Oct 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37821035
10.
Upadacitinib Therapy Reduces Ulcerative Colitis Symptoms as Early as Day 1 of Induction Treatment.
Clin Gastroenterol Hepatol
; 21(9): 2347-2358.e6, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-36464141
11.
Standardizing Scoring Conventions for Crohn's Disease Endoscopy: An International RAND/UCLA Appropriateness Study.
Clin Gastroenterol Hepatol
; 21(11): 2938-2950.e6, 2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37308036
12.
Higher vs Standard Adalimumab Induction Dosing Regimens and Two Maintenance Strategies: Randomized SERENE CD Trial Results.
Gastroenterology
; 162(7): 1876-1890, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35122766
13.
Higher vs Standard Adalimumab Induction and Maintenance Dosing Regimens for Treatment of Ulcerative Colitis: SERENE UC Trial Results.
Gastroenterology
; 162(7): 1891-1910, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35227777
14.
Effectiveness and Safety of Antiobesity Medications in Patients With Obesity and Inflammatory Bowel Disease.
Am J Gastroenterol
; 2023 Oct 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37811776
15.
Rapid and Sustained Symptom Relief in Patients With Ulcerative Colitis Treated With Filgotinib: Data From the Phase 2b/3 SELECTION Trial.
Am J Gastroenterol
; 118(1): 138-147, 2023 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36113491
16.
The Real-World Effectiveness and Safety of Ustekinumab in the Treatment of Crohn's Disease: Results From the SUCCESS Consortium.
Am J Gastroenterol
; 118(2): 317-328, 2023 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36191274
17.
Interobserver agreement of the modified Paris classification and histology prediction of colorectal lesions in patients with inflammatory bowel disease.
Gastrointest Endosc
; 97(4): 790-798.e2, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36402202
18.
Outcomes of Fecal Microbiota Transplantation for C. difficile Infection in Inflammatory Bowel Disease : A Systematic Review and Meta-analysis.
J Clin Gastroenterol
; 57(3): 285-293, 2023 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34864789
19.
Anemia and Systemic Inflammatory Markers in Patients with Perianal Disease: Hidradenitis Suppurativa and Inflammatory Bowel Disease.
Dermatology
; 239(5): 843-848, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37356426
20.
Filgotinib as induction and maintenance therapy for ulcerative colitis (SELECTION): a phase 2b/3 double-blind, randomised, placebo-controlled trial.
Lancet
; 397(10292): 2372-2384, 2021 06 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-34090625